Table 2 Comparison between patient’s subgroups I and II as regards spirometric pulmonary function in the three visits
From: Assessment of hyaluronic acid in COPD patients as a prognostic biomarker
Groups | Test of sig | ||||
|---|---|---|---|---|---|
Subgroup I (n = 30) | Subgroup II (n = 30) | U | p-value | ||
FEV1 %Pred | Visit 1 | 60.80 ± 5.37 | 34.83 ± 5.69 | 0.00 | 0.000** |
Visit 2 | 67.57 ± 6.52 | 43.67 ± 5.55 | 0.00 | 0.000** | |
Visit 3 | 70.20 ± 5.54 | 49.30 ± 5.16 | 0.00 | 0.000** | |
Fr | 54.89 | 56.00 | |||
p-value | 0.000** | 0.000** | |||
Post hoc test | P1 = 0.00** P2 = 0.00** P3 = 0.00** | P1 = 0.00** P2 = 0.00** P3 = 0.00** | |||
FVC %Pred | Visit 1 | 88.56 ± 5.14 | 73.63 ± 3.99 | 7.50 | 0.000** |
Visit 2 | 96.96 ± 5.12 | 81.53 ± 4.06 | 4.50 | 0.000** | |
Visit 3 | 99.03 ± 5.05 | 83.76 ± 3.63 | 3.50 | 0.000** | |
Fr | 60.00 | 60.00 | |||
p-value | 0.000** | 0.000** | |||
Post hoc test | P1 = 0.00**, P2 = 0.00**, P3 = 0.00** | P1 = 0.00**, P2 = 0.00**, P3 = 0.00** | |||
FEV1/FVC | Visit 1 | 68.43 ± 3.70 | 46.23 ± 5.12 | 0.00 | 0.000** |
Visit 2 | 69.80 ± 4.47 | 53.13 ± 4.70 | 2.50 | 0.000** | |
Visit 3 | 70.03 ± 3.64 | 59.50 ± 4.11 | 10.00 | 0.000** | |
Fr | 32.27 | 36.00 | |||
p-value | 0.000** | 0.000** | |||
Post hoc test | P1 = 0.00** P2 = 0.00** P3 = 0.00** | ||||